10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2010 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 2, 2011 10-K (Filed: Feb 25, 2011) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 2, 2011 | Jan 3, 2010 | Dec 28, 2008 | |
| Sales to customers | $ 61,587 | 61,897 | 63,747 [1] |
| Cost of products sold | 18,792 | 18,447 | 18,511 |
| Gross profit | 42,795 | 43,450 | 45,236 |
| Selling, marketing and administrative expenses | 19,424 | 19,801 | 21,490 |
| Research and development expense | 6,844 | 6,986 | 7,577 |
| Purchased in-process research and development (Note 20) | 181 | ||
| Interest income | (107) | (90) | (361) |
| Interest expense, net of portion capitalized (Note 4) | 455 | 451 | 435 |
| Other (income) expense, net | (768) | (526) | (1,015) |
| Restructuring (Note 22) | 1,073 | ||
| Earnings before provision for taxes on income: | 16,947 | 15,755 | 16,929 |
| Provision for taxes on income (Note 8) | 3,613 | 3,489 | 3,980 |
| Net earnings | 13,334 | 12,266 | 12,949 |
| Basic net earnings per share (Notes 1 and 15) | 4.85 | 4.45 | 4.62 |
| Diluted net earnings per share (Notes 1 and 15) | 4.78 | 4.40 | 4.57 |
| Cash dividends per share | 2.11 | 1.93 | 1.79 |
| Basic average shares outstanding (Notes 1 and 15) | 2,751,400 | 2,759,500 | 2,802,500 |
| Diluted average shares outstanding (Notes 1 and 15) | 2,788,800 | 2,789,100 | 2,835,600 |
| [1] See Note 1 for a description of the segments in which the Company operates. | |||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Jan 2, 2011 10-K (Filed: Feb 25, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 2, 2011 | Jan 3, 2010 | Dec 28, 2008 | |
| Cash flows from operating activities | |||
| Net earnings | $ 13,334 | 12,266 | 12,949 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 2,939 | 2,774 | 2,832 |
| Stock based compensation | 614 | 628 | 627 |
| Purchased in-process research and development | 181 | ||
| Deferred tax provision | 356 | (436) | 22 |
| Accounts receivable allowances | 12 | 58 | 86 |
| Changes in assets and liabilities, net of effects from acquisitions: | |||
| (Increase)/decrease in accounts receivable | (207) | 453 | (736) |
| (Increase)/decrease in inventories | (196) | 95 | (101) |
| Increase/(decrease) in accounts payable and accrued liabilities | 20 | (507) | (272) |
| (Increase)/decrease in other current and non-current assets | (574) | 1,209 | (1,600) |
| Increase in other current and non-current liabilities | 87 | 31 | 984 |
| Net cash flows from operating activities | 16,385 | 16,571 | 14,972 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (2,384) | (2,365) | (3,066) |
| Proceeds from the disposal of assets | 524 | 154 | 785 |
| Acquisitions, net of cash acquired (Note 20) | (1,269) | (2,470) | (1,214) |
| Purchases of investments | (15,788) | (10,040) | (3,668) |
| Sales of investments | 11,101 | 7,232 | 3,059 |
| Other (primarily intangibles) | (38) | (109) | (83) |
| Net cash used by investing activities | (7,854) | (7,598) | (4,187) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (5,804) | (5,327) | (5,024) |
| Repurchase of common stock | (2,797) | (2,130) | (6,651) |
| Proceeds from short-term debt | 7,874 | 9,484 | 8,430 |
| Retirement of short-term debt | (6,565) | (6,791) | (7,319) |
| Proceeds from long-term debt | 1,118 | 9 | 1,638 |
| Retirement of long-term debt | (32) | (219) | (24) |
| Proceeds from the exercise of stock options/excess tax benefits | 1,226 | 882 | 1,486 |
| Net cash used by financing activities | (4,980) | (4,092) | (7,464) |
| Effect of exchange rate changes on cash and cash equivalents | (6) | 161 | (323) |
| Increase in cash and cash equivalents | 3,545 | 5,042 | 2,998 |
| Cash and cash equivalents, beginning of year (Note 1) | 15,810 | 10,768 | |
| Cash and cash equivalents, end of year (Note 1) | 19,355 | 15,810 | 10,768 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 491 | 533 | 525 |
| Income taxes | 2,442 | 2,363 | 4,068 |
| Supplemental schedule of noncash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds | 673 | 541 | 593 |
| Conversion of debt | 1 | 2 | 0 |
| Acquisitions | |||
| Fair value of assets acquired | 1,321 | 3,345 | 1,328 |
| Fair value of liabilities assumed and non-controlling interests | (52) | (875) | (114) |
| Net cash paid for acquisitions | 1,269 | 2,470 | 1,214 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2010 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 2, 2011 10-K (Filed: Feb 25, 2011) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Jan 2, 2011 | Jan 3, 2010 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 19,355 | 15,810 |
| Marketable securities (Notes 1 and 2) | 8,303 | 3,615 |
| Accounts receivable trade, less allowances for doubtful accounts $340 (2009, $333) | 9,774 | 9,646 |
| Inventories (Notes 1 and 3) | 5,378 | 5,180 |
| Deferred taxes on income (Note 8) | 2,224 | 2,793 |
| Prepaid expenses and other receivables | 2,273 | 2,497 |
| Total current assets | 47,307 | 39,541 |
| Property, plant and equipment, net (Notes 1 and 4) | 14,553 | 14,759 |
| Intangible assets, net (Notes 1 and 5) | 16,716 | 16,323 |
| Goodwill (Notes 1 and 5) | 15,294 | 14,862 |
| Deferred taxes on income (Note 8) | 5,096 | 5,507 |
| Other assets | 3,942 | 3,690 |
| Total assets | 102,908 | 94,682 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | 7,617 | 6,318 |
| Accounts payable | 5,623 | 5,541 |
| Accrued liabilities | 4,100 | 4,625 |
| Accrued rebates, returns and promotions | 2,512 | 2,028 |
| Accrued compensation and employee related obligations | 2,642 | 2,777 |
| Accrued taxes on income | 578 | 442 |
| Total current liabilities | 23,072 | 21,731 |
| Long-term debt (Note 7) | 9,156 | 8,223 |
| Deferred taxes on income (Note 8) | 1,447 | 1,424 |
| Employee related obligations (Notes 9 and 10) | 6,087 | 6,769 |
| Other liabilities | 6,567 | 5,947 |
| Total liabilities | 46,329 | 44,094 |
| Shareholders' equity | ||
| Preferred stock - without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock - par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (Note 13) | (3,531) | (3,058) |
| Retained earnings | 77,773 | 70,306 |
| Shareholders' equity before deduction of treasury stock | 77,362 | 70,368 |
| Less: common stock held in treasury, at cost (Note 12) (381,746,000 shares and 365,522,000 shares) | 20,783 | 19,780 |
| Total shareholders' equity | 56,579 | 50,588 |
| Total liabilities and shareholders' equity | 102,908 | 94,682 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |